BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28409566)

  • 1. Combined Effects of Glucocorticoid and Noradrenergic Activity on Loss Aversion.
    Margittai Z; Nave G; Van Wingerden M; Schnitzler A; Schwabe L; Kalenscher T
    Neuropsychopharmacology; 2018 Jan; 43(2):334-341. PubMed ID: 28409566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hydrocortisone and yohimbine on decision-making under risk.
    Metz S; Waiblinger-Grigull T; Schulreich S; Chae WR; Otte C; Heekeren HR; Wingenfeld K
    Psychoneuroendocrinology; 2020 Apr; 114():104589. PubMed ID: 32028083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol boosts risky decision-making behavior in men but not in women.
    Kluen LM; Agorastos A; Wiedemann K; Schwabe L
    Psychoneuroendocrinology; 2017 Oct; 84():181-189. PubMed ID: 28750292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoid and noradrenergic activity on spatial learning and spatial memory in healthy young adults.
    Chae WR; Metz S; Weise J; Nowacki J; Piber D; Mueller SC; Wingenfeld K; Otte C
    Behav Brain Res; 2019 Nov; 373():112072. PubMed ID: 31279794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine.
    Schwager AL; Haack AK; Taha SA
    Psychopharmacology (Berl); 2014 Oct; 231(20):3941-52. PubMed ID: 24647923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic modulation of risk/reward decision making.
    Montes DR; Stopper CM; Floresco SB
    Psychopharmacology (Berl); 2015 Aug; 232(15):2681-96. PubMed ID: 25761840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic Stimulation Impairs Memory Generalization in Women.
    Kluen LM; Agorastos A; Wiedemann K; Schwabe L
    J Cogn Neurosci; 2017 Jul; 29(7):1279-1291. PubMed ID: 28253079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids, Noradrenergic Arousal, and the Control of Memory Retrieval.
    Zerbes G; Kausche FM; Müller JC; Wiedemann K; Schwabe L
    J Cogn Neurosci; 2019 Feb; 31(2):288-298. PubMed ID: 30407136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hydrocortisone and yohimbine on selective attention to emotional cues.
    Metz S; Chae WR; Deuter CE; Otte C; Wingenfeld K
    J Psychopharmacol; 2021 Jun; 35(6):755-759. PubMed ID: 33779376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the noradrenergic system on the formation of intrusive memories in women: an experimental approach with a trauma film paradigm.
    Rombold F; Wingenfeld K; Renneberg B; Hellmann-Regen J; Otte C; Roepke S
    Psychol Med; 2016 Sep; 46(12):2523-34. PubMed ID: 27335220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous cortisol causes a shift from deliberative to intuitive thinking.
    Margittai Z; Nave G; Strombach T; van Wingerden M; Schwabe L; Kalenscher T
    Psychoneuroendocrinology; 2016 Feb; 64():131-5. PubMed ID: 26658173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociable roles of glucocorticoid and noradrenergic activation on social discounting.
    Margittai Z; van Wingerden M; Schnitzler A; Joëls M; Kalenscher T
    Psychoneuroendocrinology; 2018 Apr; 90():22-28. PubMed ID: 29407513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of noradrenergic arousal on amygdala processing of fearful faces in men and women.
    Schwabe L; Höffken O; Tegenthoff M; Wolf OT
    Neuroimage; 2013 Jun; 73():1-7. PubMed ID: 23380165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous glucocorticoid and noradrenergic activity disrupts the neural basis of goal-directed action in the human brain.
    Schwabe L; Tegenthoff M; Höffken O; Wolf OT
    J Neurosci; 2012 Jul; 32(30):10146-55. PubMed ID: 22836250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition.
    Schippers MC; Schetters D; De Vries TJ; Pattij T
    Psychopharmacology (Berl); 2016 Jul; 233(14):2775-85. PubMed ID: 27251129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Lack of) Effects of noradrenergic stimulation on human working memory performance.
    Wanke N; Müller JC; Wiedemann K; Schwabe L
    Psychopharmacology (Berl); 2020 Oct; 237(10):3033-3046. PubMed ID: 32583013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Propranolol's Selective Effect on Loss Aversion.
    Sokol-Hessner P; Lackovic SF; Tobe RH; Camerer CF; Leventhal BL; Phelps EA
    Psychol Sci; 2015 Jul; 26(7):1123-30. PubMed ID: 26063441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of stress response systems on forced choice recognition in an experimental trauma film paradigm.
    Rombold-Bruehl F; Otte C; Renneberg B; Hellmann-Regen J; Bruch L; Wingenfeld K; Roepke S
    Neurobiol Learn Mem; 2018 Dec; 156():45-52. PubMed ID: 30352264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of noradrenergic and serotonergic systems in risk-based decisions between options of equivalent expected value in rats.
    Cui RS; Ruan H; Liu LY; Li XW
    Neurobiol Learn Mem; 2020 Nov; 175():107310. PubMed ID: 32890758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.
    Kuehl LK; Deuter CE; Hellmann-Regen J; Kaczmarczyk M; Otte C; Wingenfeld K
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109751. PubMed ID: 31446157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.